Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms JB-4-049 |
Target |
Action inhibitors |
Mechanism FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC56H65N11O11S |
InChIKeyYGCOKPHHDANSPA-UHFFFAOYSA-N |
CAS Registry- |